Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor–Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1Jeffrey L. Lennox, Manish Sagar, Todd T. Brown et al.|Annals of Internal Medicine|2014Cited by 260
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trialAngela R Branche, Kuleni Abebe, Nadine Rouphael et al.|Nature Medicine|2023Cited by 56
Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidaseRuipeng Lei, Nicholas C. Wu, Wooseob Kim et al.|Immunity|2023Cited by 46
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary AnalysesAngela R Branche, Kuleni Abebe, Nadine Rouphael et al.|medRxiv|2022Cited by 30